Correlation between antihypertensive drugs and cerebral hemodynamic parameters: insights from observational findings

Michel Ferreira Machado1, Henrique Cotchi Simbo Muela2, Valeria Aparecida Costa-Hong2

  • 1Department of Neurology, Hospital das Clínicas, University of São Paulo Medical School, Brazil.

Insights

Antihypertensives (AHD) affect cerebral autoregulation (CA) and arterial remodelling. This study found that despite impaired CO2 reactivity in hypertensive individuals, their arterial tonus and CA were comparable to non-hypertensives, suggesting PI may not reflect cerebrovascular resistance.

Area of Science:

  • Neuroscience
  • Cardiovascular Science
  • Medical Research

Background:

  • Antihypertensives (AHD) can influence cerebral autoregulation (CA).
  • AHD may attenuate hypertrophic concentric remodeling of arterioles.
  • Understanding the interplay between AHD, CA, and cerebral artery properties is crucial.

Purpose of the Study:

  • To examine associations between antihypertensives (AHD), cerebral autoregulation (CA).
  • To investigate structural and functional properties of cerebral arteries in relation to AHD and CA.
  • To compare cerebrovascular parameters between hypertensive and non-hypertensive individuals.

Main Methods:

  • Observational, cross-sectional study of 115 volunteers (non-hypertensive, controlled, and uncontrolled hypertensive groups).
  • Simultaneous measurement of systemic blood pressure (BP) and middle cerebral artery blood flow velocity (CBFV) using digital plethysmography and transcranial Doppler.
  • Analysis of beat-to-beat parameters including critical closing pressure (CrCP), resistance-area product (RAP), autoregulation index (ARI), pulsatility index (PI), and CO2 reactivity.

Main Results:

  • Uncontrolled hypertensive individuals using diuretics or α2-agonists showed significantly lower pulsatility index (PI) despite higher resistance-area product (RAP).
  • Impaired CO2 reactivity was prevalent in both hypertensive groups.
  • Autoregulation index (ARI), critical closing pressure (CrCP), and CBFV did not differ between hypertensive and non-hypertensive groups and did not correlate with AHD use.

Conclusions:

  • Pulsatility index (PI) may not accurately reflect cerebrovascular resistance due to chronic arterial remodeling, unlike RAP.
  • Despite impaired CO2 reactivity, hypertensive individuals exhibit arterial tonus and CA comparable to non-hypertensives.
  • Further studies with untreated hypertensive control groups are needed for definitive conclusions.
Abstract

Related Concept Videos

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
45
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
479
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
391